NL-OMON21253
Recruiting
Not Applicable
Biomarkers in Atopic Dermatitis, The Netherlands
Amsterdam UMC, Academic Medical Center0 sites110 target enrollmentTBD
Conditions<p>Atopic dermatitis, atopic eczema</p>
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- <p>Atopic dermatitis, atopic eczema</p>
- Sponsor
- Amsterdam UMC, Academic Medical Center
- Enrollment
- 110
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient has a diagnosis of AD, based on the U.K. working party’s diagnostic criteria;
- •\-Starts with any type of phototherapy (e.g. UVB) or systemic immunomodulating therapy (e.g. ciclosporin, systemic glucocorticosteroids, azathioprine, methotrexate, mycophenolic acid, dupilumab);
- •\-Has voluntarily signed and dated an informed consent prior to any study related procedure or has a legal representative to do so and is willing to comply with the requirements of this study protocol.
Exclusion Criteria
- •\-Patient uses only (systemic) antibiotics or antihistamines;
- •\-Patient starts with systemic immunomodulating therapy for another indication than atopic dermatitis;
- •\-Insufficient understanding of the study by the patient or parent/legal representative;
- •\-Patient does not participate in the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Biomarkers in Atopic Dermatitis and Psoriasis The NetherlandsAtopic dermatitisatopic eczema10014982NL-OMON48036Academisch Medisch Centrum110
Active, not recruiting
Not Applicable
AMBITIOUSAtopic Dermatitis Biomarker Identification Trial in Omalizumab UsageSingle- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitis - AMBITIOUSAMBITIOUS is a trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitisAtopische Dermatitis is a common inflammatory skin disease showing chronically relapsing eczema and high association with elevated serum IgE levels.MedDRA version: 14.0Level: LLTClassification code 10029264Term: Neurodermatitis aggravatedSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-018559-84-DEMedizinische Fakultät der technischen Universität Muenchen20
Active, not recruiting
Not Applicable
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)Dermatitis AtopicNCT03849716Sanofi266
Completed
Not Applicable
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trialAtopic dermatitisJPRN-UMIN000041204Takashima Clinic57
Recruiting
Not Applicable
EVALUATION OF BIOMARKERS OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS WHOSE DISEASE IS NOT ADEQUATELY CONTROLLED WITH TOPICAL PRESCRIPTION THERAPIES OR WHEN THOSE THERAPIES ARE NOT MEDICALLY ADVISABLENL-OMON48261Sanofi-aventis12